Introduction to SAC-SG
SAC-SG (Sigma Anti-bonding Calcium – Glucose) is a novel cancer treatment approach that targets tumor cells specifically, minimizing damage to healthy tissues. By leveraging cancer cells’ unique metabolic needs, SAC-SG disrupts their growth and triggers apoptosis (cell death).
Mechanism of Action
- Targeted Delivery through Glucose Pathways
Cancer cells require large amounts of glucose for their rapid growth and proliferation. SAC-SG binds to glucose, exploiting these cells’ high glucose uptake to selectively deliver calcium into the tumor cells. Once inside, the calcium ions disrupt the cells’ calcium homeostasis, triggering apoptosis.
Illustration of SAC Calcium-Glucose Structure .
- Generation of Oxidative Stress
In the low oxygen environment typical of tumor cells, SAC-SG dissociates into free radicals, which causes oxidative damage and further promotes cancer cell death.
Diagram showing the absorption of SAC-SG and oxidation by free radicals in tumor cells.
Scientific Evidence and Case Studies
- Case Study: Mr. Peter Jung – Stage 4 Breast Cancer
Mr. Peter Jung, a 67-year-old patient diagnosed with stage 4 breast cancer with metastasis to the bones, underwent SAC-SG therapy alongside standard treatments. The results were promising:
- Tumor marker levels significantly decreased from 470 (before treatment) to 35 (after 302 days of treatment).
- Pain levels reduced dramatically, improving his overall quality of life.
Before and after CT scans of cancer treatment .
- Case Study: Ms. Reidel – Stage 4 Rectal Cancer
An 80-year-old patient, Ms. Reidel, with stage 4 rectal cancer, showed substantial improvement after undergoing SAC-SG therapy:
- Significant reduction in tumor markers and improved quality of life was observed over a period of several months.
Preclinical and Clinical Studies
Multiple preclinical and clinical studies have demonstrated the efficacy of SAC-SG in reducing tumor growth and improving patient outcomes. In animal models, SAC-SG was shown to significantly reduce tumor sizes without notable side effects, supporting its potential as a safe and effective cancer therapy.
PET CT scans showing the effectiveness of SAC-SG in reducing tumor size .
Benefits of SAC-SG Over Conventional Therapies
- Selective Targeting: SAC-SG focuses on cancer cells without harming normal tissues, unlike traditional chemotherapy and radiation.
- Reduced Side Effects: The treatment has shown minimal adverse effects, making it a promising alternative or complement to conventional therapies.
- Improvement in Quality of Life: Patients treated with SAC-SG report reduced pain and improved mobility and mood, contributing to a better overall prognosis.
Conclusion
SAC-SG represents a revolutionary approach to cancer therapy, focusing on targeted delivery and minimal side effects. By exploiting cancer cells’ metabolic requirements, SAC-SG opens a new pathway in non-toxic cancer treatment.
